Koninklijke DSM N.V Key Executives
This section highlights Koninklijke DSM N.V's key executives, including their titles and compensation details.
Find Contacts at Koninklijke DSM N.V
(Showing 0 of )
Koninklijke DSM N.V Earnings
This section highlights Koninklijke DSM N.V's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
---|---|---|---|---|---|
Read Transcript | Q3 | 2024 | 2024-11-01 | N/A | N/A |
Read Transcript | Q2 | 2024 | 2024-08-03 | N/A | N/A |
Read Transcript | Q1 | 2024 | 2024-05-04 | N/A | N/A |

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.
$114.05
Stock Price
$763.73M
Market Cap
-
Employees
Heerlen, None
Location
Financial Statements
Access annual & quarterly financial statements for Koninklijke DSM N.V, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
Breakdown | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 |
---|---|---|---|---|---|
Revenue | $8.39B | $9.20B | $8.11B | $9.01B | $9.27B |
Cost of Revenue | $5.70B | $6.04B | $5.33B | $5.96B | $5.86B |
Gross Profit | $2.69B | $3.16B | $2.78B | $3.05B | $3.40B |
Gross Profit Ratio | 32.06% | 34.40% | 34.25% | 33.88% | 36.74% |
Research and Development Expenses | $295.00M | $323.00M | $398.00M | $349.00M | $348.00M |
General and Administrative Expenses | $534.00M | $517.00M | $469.00M | $525.00M | $530.00M |
Selling and Marketing Expenses | $1.24B | $1.27B | $1.15B | $1.26B | $1.30B |
Selling General and Administrative Expenses | $1.77B | $1.79B | $1.62B | $1.79B | $1.83B |
Other Expenses | $- | $29.00M | $84.00M | $20.00M | $7.00M |
Operating Expenses | $-2.01B | $2.14B | $2.10B | $2.16B | $2.19B |
Cost and Expenses | $3.69B | $8.18B | $7.43B | $8.11B | $8.05B |
Interest Income | $- | $3.00M | $17.00M | $9.00M | $13.00M |
Interest Expense | $-82.00M | $110.00M | $98.00M | $111.00M | $115.00M |
Depreciation and Amortization | $-582.00M | $689.00M | $740.00M | $563.00M | $509.00M |
EBITDA | $1.23B | $1.71B | $1.40B | $1.52B | $1.73B |
EBITDA Ratio | 14.71% | 18.58% | 17.30% | 16.84% | 18.70% |
Operating Income | $1.82B | $1.02B | $662.00M | $954.00M | $1.25B |
Operating Income Ratio | 21.64% | 11.09% | 8.17% | 10.59% | 13.43% |
Total Other Income Expenses Net | $-1.22B | $-106.00M | $-67.00M | $-92.00M | $-101.00M |
Income Before Tax | $599.00M | $915.00M | $595.00M | $862.00M | $1.14B |
Income Before Tax Ratio | 7.14% | 9.94% | 7.34% | 9.57% | 12.34% |
Income Tax Expense | $124.00M | $168.00M | $106.00M | $152.00M | $194.00M |
Net Income | $475.00M | $747.00M | $506.00M | $758.00M | $1.08B |
Net Income Ratio | 5.66% | 8.12% | 6.24% | 8.41% | 11.62% |
EPS | $2.74 | $4.31 | $2.91 | $4.27 | $6.11 |
EPS Diluted | $2.74 | $4.31 | $2.89 | $4.24 | $6.11 |
Weighted Average Shares Outstanding | 173.62M | 172.65M | 171.54M | 175.73M | 175.32M |
Weighted Average Shares Outstanding Diluted | 173.62M | 173.40M | 172.43M | 176.82M | 176.32M |
SEC Filing | Source | Source | Source | Source | Source |
Breakdown | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | December 31, 2018 | September 30, 2018 | June 30, 2018 | March 31, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $2.14B | $2.14B | $2.06B | $2.06B | $1.39B | $2.36B | $1.76B | $1.76B | $2.08B | $1.96B | $2.24B | $2.29B | $2.15B | $2.29B | $2.28B | $2.29B | $2.21B | $2.27B | $2.36B | $2.44B |
Cost of Revenue | $1.51B | $1.51B | $1.34B | $1.34B | $615.00M | $3.02B | $1.13B | $1.13B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Gross Profit | $632.00M | $632.00M | $713.00M | $713.00M | $779.00M | $-662.00M | $632.50M | $632.50M | $2.08B | $1.96B | $2.24B | $2.29B | $2.15B | $2.29B | $2.28B | $2.29B | $2.21B | $2.27B | $2.36B | $2.44B |
Gross Profit Ratio | 29.60% | 29.60% | 34.70% | 34.70% | 55.90% | -28.10% | 36.00% | 36.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research and Development Expenses | $- | $- | $- | $- | $118.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
General and Administrative Expenses | $- | $- | $- | $- | $216.50M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Selling and Marketing Expenses | $- | $- | $- | $- | $537.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Selling General and Administrative Expenses | $- | $- | $- | $- | $754.50M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $-2.00B | $-1.77B | $-1.85B | $-2.09B | $-1.98B | $-2.02B | $-2.03B | $-2.02B | $-2.01B | $-2.02B | $-1.97B | $-2.02B |
Operating Expenses | $-489.50M | $-489.50M | $-512.00M | $-512.00M | $-1.76B | $1.04B | $-425.50M | $-425.50M | $-2.00B | $-1.77B | $-1.85B | $-2.09B | $-1.98B | $-2.02B | $-2.03B | $-2.02B | $-2.01B | $-2.02B | $-1.97B | $-2.02B |
Cost and Expenses | $1.02B | $1.02B | $832.50M | $832.50M | $-1.15B | $4.07B | $700.50M | $700.50M | $-2.00B | $-1.77B | $-1.85B | $-2.09B | $-1.98B | $-2.02B | $-2.03B | $-2.02B | $-2.01B | $-2.02B | $-1.97B | $-2.02B |
Interest Income | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-29.00M | $- | $- | $-25.00M | $-18.00M |
Interest Expense | $-24.50M | $-24.50M | $-19.50M | $-19.50M | $-13.50M | $-10.50M | $-32.50M | $-32.50M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Depreciation and Amortization | $-148.75M | $-148.00M | $-148.00M | $-148.00M | $-187.00M | $-138.00M | $-135.00M | $-135.00M | $31.00M | $52.75K | $51.12K | $47.30K | $19.00M | $44.65K | $40.96K | $40.37K | $14.00M | $- | $1.97B | $- |
EBITDA | $336.25M | $335.50M | $347.00M | $347.00M | $294.50M | $346.50M | $332.00M | $332.00M | $107.00M | $192.00M | $388.00M | $207.00M | $189.00M | $266.00M | $247.00M | $271.00M | $210.00M | $249.00M | $2.36B | $411.00M |
EBITDA Ratio | 15.73% | 15.70% | 16.87% | 16.87% | 21.13% | 14.69% | 18.88% | 18.88% | 5.14% | 9.79% | 17.33% | 9.03% | 8.78% | 11.62% | 10.85% | 11.82% | 9.51% | 10.99% | 100.00% | 16.88% |
Operating Income | $485.00M | $483.50M | $495.00M | $495.00M | $481.50M | $208.50M | $197.00M | $197.00M | $76.00M | $192.00M | $388.00M | $207.00M | $170.00M | $266.00M | $247.00M | $271.00M | $196.00M | $249.00M | $389.00M | $411.00M |
Operating Income Ratio | 22.69% | 22.62% | 24.06% | 24.06% | 34.54% | 8.84% | 11.20% | 11.20% | 3.65% | 9.79% | 17.33% | 9.03% | 7.90% | 11.62% | 10.85% | 11.82% | 8.88% | 10.99% | 16.49% | 16.88% |
Total Other Income Expenses Net | $-367.00M | $-365.50M | $-313.50M | $-313.50M | $-250.00M | $164.00M | $-22.50M | $-22.50M | $-15.00M | $-21.00M | $-178.00M | $-13.00M | $-11.00M | $-24.00M | $-28.00M | $-29.00M | $-26.00M | $-32.00M | $-25.00M | $-18.00M |
Income Before Tax | $118.00M | $118.00M | $181.50M | $181.50M | $231.50M | $372.50M | $174.50M | $174.50M | $61.00M | $171.00M | $210.00M | $194.00M | $159.00M | $242.00M | $219.00M | $242.00M | $170.00M | $217.00M | $364.00M | $393.00M |
Income Before Tax Ratio | 5.52% | 5.52% | 8.82% | 8.82% | 16.61% | 15.80% | 9.92% | 9.92% | 2.93% | 8.72% | 9.38% | 8.46% | 7.39% | 10.57% | 9.62% | 10.56% | 7.70% | 9.58% | 15.43% | 16.14% |
Income Tax Expense | $26.00M | $26.00M | $36.00M | $36.00M | $20.00M | $39.00M | $32.00M | $32.00M | $17.00M | $33.00M | $37.00M | $30.00M | $30.00M | $42.00M | $36.00M | $44.00M | $23.00M | $40.00M | $64.00M | $67.00M |
Net Income | $92.00M | $92.00M | $145.50M | $145.50M | $211.50M | $331.50M | $139.50M | $139.50M | $99.00M | $167.00M | $101.00M | $167.00M | $123.00M | $236.00M | $204.00M | $195.00M | $258.00M | $188.00M | $301.00M | $330.00M |
Net Income Ratio | 4.30% | 4.30% | 7.07% | 7.07% | 15.17% | 14.06% | 7.93% | 7.93% | 4.76% | 8.52% | 4.51% | 7.28% | 5.72% | 10.31% | 8.96% | 8.51% | 11.68% | 8.30% | 12.76% | 13.55% |
EPS | $0.53 | $0.53 | $0.84 | $0.84 | $1.22 | $1.91 | $0.81 | $0.81 | $0.00 | $0.96 | $0.58 | $0.96 | $0.00 | $1.20 | $1.14 | $1.10 | $0.00 | $1.06 | $1.70 | $1.88 |
EPS Diluted | $0.53 | $0.53 | $0.84 | $0.84 | $1.22 | $1.91 | $0.81 | $0.81 | $0.00 | $0.96 | $0.58 | $0.96 | $0.00 | $1.20 | $1.14 | $1.10 | $0.00 | $1.06 | $1.70 | $1.88 |
Weighted Average Shares Outstanding | 173.42M | 173.42M | 173.36M | 173.36M | 173.18M | 173.89M | 173.10M | 173.10M | - | 171.80M | 170.80M | 171.40M | - | 176.20M | 176.50M | 176.10M | - | 175.70M | 175.20M | 174.80M |
Weighted Average Shares Outstanding Diluted | 173.42M | 173.42M | 173.36M | 173.36M | 173.18M | 173.89M | 173.10M | 173.10M | - | 171.80M | 170.80M | 171.40M | - | 176.20M | 176.50M | 176.10M | - | 175.70M | 175.20M | 174.80M |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
Breakdown | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 |
---|---|---|---|---|---|
Cash and Cash Equivalents | $2.75B | $1.56B | $871.00M | $800.00M | $1.28B |
Short Term Investments | $125.00M | $489.00M | $43.00M | $688.00M | $1.28B |
Cash and Short Term Investments | $2.88B | $2.05B | $914.00M | $1.49B | $2.56B |
Net Receivables | $- | $- | $- | $- | $1.57M |
Inventory | $2.34B | $2.30B | $1.88B | $2.02B | $1.99B |
Other Current Assets | $- | $- | $- | $- | $1.76B |
Total Current Assets | $8.13B | $6.13B | $5.42B | $5.22B | $6.31B |
Property Plant Equipment Net | $3.58B | $3.96B | $3.77B | $4.04B | $3.51B |
Goodwill | $2.98B | $2.95B | $2.52B | $2.28B | $1.91B |
Intangible Assets | $2.16B | $2.36B | $1.94B | $1.23B | $1.18B |
Goodwill and Intangible Assets | $5.15B | $5.31B | $4.46B | $3.52B | $3.09B |
Long Term Investments | $196.00M | $-230.00M | $278.00M | $-376.00M | $-899.00M |
Tax Assets | $- | $203.00M | $239.00M | $217.00M | $248.00M |
Other Non-Current Assets | $-8.92B | $644.00M | $193.00M | $823.00M | $1.38B |
Total Non-Current Assets | $8.92B | $9.88B | $8.94B | $8.22B | $7.33B |
Other Assets | $356.00M | $- | $- | $- | $- |
Total Assets | $- | $16.01B | $14.36B | $13.44B | $13.64B |
Account Payables | $1.41B | $1.57B | $1.22B | $1.34B | $1.43B |
Short Term Debt | $- | $104.00M | $107.00M | $189.00M | $380.00M |
Tax Payables | $- | $137.00M | $102.00M | $88.00M | $158.00M |
Deferred Revenue | $- | $746.00M | $862.00M | $604.00M | $158.00M |
Other Current Liabilities | $1.17B | $-127.00M | $-25.00M | $-63.00M | $445.00M |
Total Current Liabilities | $2.58B | $2.43B | $2.26B | $2.16B | $2.57B |
Long Term Debt | $2.84B | $2.99B | $3.48B | $2.46B | $2.27B |
Deferred Revenue Non-Current | $- | $62.00M | $76.00M | $65.00M | $39.00M |
Deferred Tax Liabilities Non-Current | $- | $485.00M | $433.00M | $296.00M | $254.00M |
Other Non-Current Liabilities | $- | $649.00M | $625.00M | $620.00M | $690.00M |
Total Non-Current Liabilities | $2.84B | $4.18B | $4.61B | $3.44B | $3.25B |
Other Liabilities | $1.14B | $- | $- | $- | $- |
Total Liabilities | $6.56B | $6.62B | $6.88B | $5.61B | $5.83B |
Preferred Stock | $- | $- | $- | $- | $- |
Common Stock | $328.00M | $328.00M | $338.00M | $338.00M | $338.00M |
Retained Earnings | $9.78B | $8.54B | $7.79B | $7.71B | $7.38B |
Accumulated Other Comprehensive Income Loss | $- | $- | $- | $- | $- |
Other Total Stockholders Equity | $-10.11B | $450.00M | $-730.00M | $-320.00M | $63.00M |
Total Stockholders Equity | $10.11B | $9.32B | $7.40B | $7.73B | $7.78B |
Total Equity | $10.11B | $9.40B | $7.49B | $7.83B | $7.82B |
Total Liabilities and Stockholders Equity | $- | $16.01B | $14.36B | $13.44B | $13.64B |
Minority Interest | $- | $79.00M | $88.00M | $104.00M | $33.00M |
Total Liabilities and Total Equity | $- | $16.01B | $14.36B | $13.44B | $13.64B |
Total Investments | $321.00M | $259.00M | $321.00M | $312.00M | $378.00M |
Total Debt | $- | $3.09B | $3.59B | $2.65B | $2.65B |
Net Debt | $-2.75B | $1.53B | $2.71B | $1.85B | $1.37B |
Balance Sheet Charts
Breakdown | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | December 31, 2018 | September 30, 2018 | June 30, 2018 | March 31, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $2.75B | $2.75B | $792.00M | $792.00M | $1.56B | $1.56B | $1.64B | $1.64B | $871.00M | $1.69B | $1.30B | $1.40B | $800.00M | $926.00M | $1.14B | $1.04B | $1.28B | $997.00M | $813.00M | $1.09B |
Short Term Investments | $125.00M | $125.00M | $838.00M | $838.00M | $489.00M | $489.00M | $215.00M | $215.00M | $43.00M | $40.00M | $655.00M | $195.00M | $688.00M | $853.00M | $1.15B | $1.43B | $1.28B | $1.00B | $1.01B | $954.00M |
Cash and Short Term Investments | $2.88B | $2.88B | $1.63B | $1.63B | $2.05B | $2.05B | $1.85B | $1.85B | $914.00M | $1.73B | $1.96B | $1.59B | $1.49B | $1.78B | $2.29B | $2.47B | $2.56B | $2.00B | $1.82B | $2.04B |
Net Receivables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Inventory | $2.34B | $2.34B | $2.39B | $2.39B | $2.30B | $2.30B | $2.10B | $2.10B | $1.88B | $1.95B | $2.18B | $2.14B | $2.02B | $2.12B | $2.07B | $2.06B | $1.99B | $2.00B | $2.02B | $1.93B |
Other Current Assets | $- | $- | $3.56B | $- | $1.78B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Current Assets | $8.13B | $8.13B | $7.58B | $7.58B | $6.13B | $6.13B | $5.81B | $5.81B | $5.42B | $6.30B | $5.89B | $5.64B | $5.22B | $5.79B | $6.27B | $6.55B | $6.31B | $6.04B | $5.98B | $5.96B |
Property Plant Equipment Net | $3.58B | $3.58B | $3.57B | $3.57B | $3.96B | $3.96B | $3.75B | $3.75B | $3.77B | $3.65B | $4.04B | $4.01B | $4.04B | $3.93B | $3.76B | $3.80B | $3.51B | $3.38B | $3.35B | $3.25B |
Goodwill | $2.98B | $2.98B | $- | $- | $2.95B | $2.93B | $- | $- | $2.52B | $- | $- | $- | $2.28B | $- | $- | $- | $1.91B | $- | $- | $- |
Intangible Assets | $2.16B | $2.16B | $- | $5.19B | $2.36B | $2.38B | $- | $4.69B | $1.94B | $- | $- | $- | $1.23B | $- | $- | $- | $1.18B | $- | $- | $- |
Goodwill and Intangible Assets | $5.15B | $5.15B | $5.19B | $5.19B | $5.31B | $5.31B | $4.69B | $4.69B | $4.46B | $3.69B | $4.20B | $3.49B | $3.52B | $3.43B | $3.23B | $3.26B | $3.09B | $3.08B | $3.04B | $2.98B |
Long Term Investments | $196.00M | $196.00M | $-572.00M | $266.00M | $-230.00M | $259.00M | $266.00M | $69.00M | $278.00M | $312.00M | $-234.00M | $214.00M | $-376.00M | $-398.00M | $-738.00M | $-1.00B | $-899.00M | $-388.00M | $-413.00M | $-228.00M |
Tax Assets | $- | $- | $133.00M | $- | $203.00M | $- | $224.00M | $- | $239.00M | $226.00M | $231.00M | $225.00M | $217.00M | $192.00M | $215.00M | $233.00M | $248.00M | $245.00M | $287.00M | $292.00M |
Other Non-Current Assets | $-8.92B | $-8.92B | $951.00M | $-9.03B | $644.00M | $-9.53B | $700.00M | $-8.51B | $386.00M | $192.00M | $1.42B | $474.00M | $1.65B | $1.73B | $2.32B | $2.89B | $2.76B | $2.04B | $1.02B | $1.95B |
Total Non-Current Assets | $8.92B | $8.92B | $9.27B | $9.03B | $9.88B | $9.53B | $9.28B | $8.51B | $8.94B | $7.97B | $8.94B | $8.18B | $8.22B | $8.02B | $7.63B | $7.74B | $7.33B | $7.34B | $7.29B | $7.26B |
Other Assets | $356.00M | $356.00M | $- | $246.00M | $- | $358.00M | $- | $771.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Assets | $- | $- | $16.85B | $- | $16.01B | $- | $15.10B | $- | $14.36B | $14.27B | $14.83B | $13.81B | $13.44B | $13.81B | $13.90B | $14.29B | $13.64B | $13.38B | $13.28B | $13.23B |
Account Payables | $1.41B | $1.41B | $1.54B | $1.54B | $1.57B | $1.56B | $1.45B | $1.45B | $1.22B | $1.18B | $1.47B | $1.55B | $1.34B | $1.36B | $1.45B | $1.47B | $1.43B | $1.39B | $1.48B | $1.65B |
Short Term Debt | $- | $- | $98.00M | $- | $104.00M | $- | $135.00M | $- | $107.00M | $316.00M | $605.00M | $450.00M | $189.00M | $126.00M | $438.00M | $429.00M | $380.00M | $110.00M | $86.00M | $88.00M |
Tax Payables | $- | $- | $97.00M | $- | $137.00M | $- | $93.00M | $- | $102.00M | $83.00M | $66.00M | $43.00M | $88.00M | $91.00M | $88.00M | $99.00M | $158.00M | $130.00M | $135.00M | $108.00M |
Deferred Revenue | $- | $- | $- | $- | $- | $- | $195.00M | $- | $862.00M | $450.00M | $203.00M | $215.00M | $604.00M | $250.00M | $221.00M | $237.00M | $723.00M | $236.00M | $248.00M | $234.00M |
Other Current Liabilities | $1.17B | $1.17B | $1.28B | $1.48B | $619.00M | $869.00M | $458.00M | $881.00M | $-25.00M | $319.00M | $499.00M | $436.00M | $-63.00M | $375.00M | $496.00M | $440.00M | $-120.00M | $377.00M | $428.00M | $415.00M |
Total Current Liabilities | $2.58B | $2.58B | $3.02B | $3.02B | $2.43B | $2.43B | $2.33B | $2.33B | $2.26B | $2.35B | $2.85B | $2.70B | $2.16B | $2.21B | $2.69B | $2.68B | $2.57B | $2.25B | $2.38B | $2.49B |
Long Term Debt | $2.84B | $2.84B | $2.98B | $2.98B | $2.99B | $2.84B | $2.56B | $2.99B | $3.48B | $2.90B | $2.91B | $1.92B | $2.46B | $1.89B | $1.86B | $1.90B | $2.27B | $2.10B | $2.09B | $2.04B |
Deferred Revenue Non-Current | $- | $- | $- | $- | $62.00M | $- | $428.00M | $- | $76.00M | $554.00M | $582.00M | $546.00M | $65.00M | $571.00M | $570.00M | $535.00M | $39.00M | $472.00M | $482.00M | $507.00M |
Deferred Tax Liabilities Non-Current | $- | $- | $491.00M | $- | $485.00M | $- | $499.00M | $- | $433.00M | $351.00M | $360.00M | $283.00M | $296.00M | $270.00M | $248.00M | $241.00M | $254.00M | $279.00M | $283.00M | $254.00M |
Other Non-Current Liabilities | $- | $- | $534.00M | $- | $649.00M | $- | $255.00M | $- | $625.00M | $158.00M | $166.00M | $154.00M | $620.00M | $143.00M | $116.00M | $178.00M | $690.00M | $193.00M | $159.00M | $175.00M |
Total Non-Current Liabilities | $2.84B | $2.84B | $4.01B | $2.98B | $4.18B | $2.84B | $4.17B | $2.99B | $4.61B | $4.51B | $4.60B | $3.45B | $3.44B | $3.44B | $3.37B | $3.39B | $3.25B | $3.51B | $3.49B | $3.49B |
Other Liabilities | $1.14B | $1.14B | $- | $1.02B | $- | $1.35B | $- | $1.18B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities | $6.56B | $6.56B | $7.03B | $7.03B | $6.62B | $6.62B | $6.50B | $6.50B | $6.88B | $6.86B | $7.45B | $6.15B | $5.61B | $5.65B | $6.06B | $6.06B | $5.83B | $5.76B | $5.87B | $5.98B |
Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock | $328.00M | $328.00M | $328.00M | $328.00M | $328.00M | $328.00M | $- | $8.52B | $338.00M | $- | $- | $- | $338.00M | $- | $- | $- | $338.00M | $- | $- | $- |
Retained Earnings | $9.78B | $9.78B | $8.55B | $8.55B | $8.54B | $8.54B | $- | $- | $7.79B | $- | $- | $- | $7.71B | $- | $- | $- | $7.38B | $- | $- | $- |
Accumulated Other Comprehensive Income Loss | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Total Stockholders Equity | $-10.11B | $-10.11B | $851.00M | $-8.88B | $450.00M | $-8.87B | $- | $-8.52B | $-730.00M | $- | $- | $- | $-320.00M | $- | $- | $- | $63.00M | $- | $- | $- |
Total Stockholders Equity | $10.11B | $10.11B | $9.73B | $8.88B | $9.32B | $8.87B | $8.52B | $8.52B | $7.40B | $7.32B | $7.28B | $7.56B | $7.73B | $8.06B | $7.79B | $8.17B | $7.78B | $7.59B | $7.37B | $7.21B |
Total Equity | $10.11B | $10.11B | $9.82B | $8.88B | $9.40B | $- | $8.60B | $- | $7.49B | $7.41B | $7.38B | $7.66B | $7.83B | $8.16B | $7.84B | $8.23B | $7.82B | $7.62B | $7.40B | $7.25B |
Total Liabilities and Stockholders Equity | $- | $- | $16.85B | $- | $16.01B | $- | $15.10B | $- | $14.36B | $14.27B | $14.83B | $13.81B | $13.44B | $13.81B | $13.90B | $14.29B | $13.64B | $13.38B | $13.28B | $13.23B |
Minority Interest | $- | $- | $92.00M | $- | $79.00M | $- | $79.00M | $- | $88.00M | $91.00M | $101.00M | $103.00M | $104.00M | $99.00M | $54.00M | $57.00M | $33.00M | $35.00M | $36.00M | $36.00M |
Total Liabilities and Total Equity | $- | $- | $16.85B | $- | $16.01B | $- | $15.10B | $- | $14.36B | $14.27B | $14.83B | $13.81B | $13.44B | $13.81B | $13.90B | $14.29B | $13.64B | $13.38B | $13.28B | $13.23B |
Total Investments | $321.00M | $321.00M | $266.00M | $1.10B | $259.00M | $748.00M | $481.00M | $284.00M | $321.00M | $352.00M | $421.00M | $409.00M | $312.00M | $455.00M | $411.00M | $428.00M | $378.00M | $613.00M | $593.00M | $726.00M |
Total Debt | $- | $- | $3.08B | $- | $3.09B | $- | $3.12B | $- | $3.59B | $3.77B | $4.10B | $2.92B | $2.65B | $2.58B | $2.87B | $2.86B | $2.65B | $2.68B | $2.65B | $2.64B |
Net Debt | $-2.75B | $-2.75B | $2.29B | $-792.00M | $1.53B | $-1.56B | $1.48B | $-1.64B | $2.71B | $2.08B | $2.80B | $1.52B | $1.85B | $1.66B | $1.73B | $1.82B | $1.37B | $1.68B | $1.84B | $1.55B |
Annual Cash Flow
Breakdown | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 |
---|---|---|---|---|---|
Net Income | $1.70B | $1.68B | $508.00M | $764.00M | $1.08B |
Depreciation and Amortization | $632.00M | $681.00M | $740.00M | $632.00M | $509.00M |
Deferred Income Tax | $- | $-920.00M | $47.00M | $-93.00M | $-60.00M |
Stock Based Compensation | $35.00M | $22.00M | $29.00M | $34.00M | $25.00M |
Change in Working Capital | $-575.00M | $-164.00M | $35.00M | $13.00M | $-279.00M |
Accounts Receivables | $-133.00M | $- | $- | $- | $- |
Inventory | $-442.00M | $-323.00M | $-36.00M | $114.00M | $-166.00M |
Accounts Payables | $- | $- | $- | $- | $- |
Other Working Capital | $- | $159.00M | $71.00M | $-101.00M | $-113.00M |
Other Non Cash Items | $-827.00M | $128.00M | $135.00M | $35.00M | $117.00M |
Net Cash Provided by Operating Activities | $965.00M | $1.43B | $1.49B | $1.39B | $1.39B |
Investments in Property Plant and Equipment | $-506.00M | $-577.00M | $-626.00M | $-641.00M | $-693.00M |
Acquisitions Net | $- | $1.09B | $-1.53B | $-519.00M | $294.00M |
Purchases of Investments | $- | $-2.11B | $-488.00M | $-1.25B | $-1.62B |
Sales Maturities of Investments | $- | $1.75B | $1.16B | $1.78B | $1.22B |
Other Investing Activities | $1.38B | $63.00M | $6.00M | $99.00M | $192.00M |
Net Cash Used for Investing Activities | $876.00M | $208.00M | $-1.48B | $-525.00M | $-605.00M |
Debt Repayment | $- | $- | $- | $- | $- |
Common Stock Issued | $- | $34.00M | $63.00M | $180.00M | $97.00M |
Common Stock Repurchased | $-210.00M | $-165.00M | $-309.00M | $-869.00M | $-236.00M |
Dividends Paid | $-345.00M | $-266.00M | $-289.00M | $-291.00M | $-225.00M |
Other Financing Activities | $-300.00M | $-718.00M | $372.00M | $-1.04B | $-176.00M |
Net Cash Used Provided by Financing Activities | $-645.00M | $-984.00M | $83.00M | $-1.33B | $-401.00M |
Effect of Forex Changes on Cash | $-2.00M | $39.00M | $-24.00M | $-9.00M | $-3.00M |
Net Change in Cash | $1.19B | $690.00M | $71.00M | $-481.00M | $382.00M |
Cash at End of Period | $2.75B | $1.56B | $871.00M | $800.00M | $1.28B |
Cash at Beginning of Period | $1.56B | $871.00M | $800.00M | $1.28B | $899.00M |
Operating Cash Flow | $965.00M | $1.43B | $1.49B | $1.39B | $1.39B |
Capital Expenditure | $-506.00M | $-577.00M | $-626.00M | $-641.00M | $-693.00M |
Free Cash Flow | $459.00M | $850.00M | $868.00M | $744.00M | $698.00M |
Cash Flow Charts
Breakdown | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 | December 31, 2019 | September 30, 2019 | June 30, 2019 | March 31, 2019 | December 31, 2018 | September 30, 2018 | June 30, 2018 | March 31, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $625.00M | $625.00M | $225.00M | $225.00M | $334.00M | $334.00M | $504.00M | $504.00M | $-608.00M | $370.00M | $388.00M | $358.00M | $-475.00M | $416.00M | $407.00M | $416.00M | $-335.00M | $385.00M | $503.00M | $526.00M |
Depreciation and Amortization | $-148.00M | $-148.00M | $148.00M | $148.00M | $212.50M | $163.50M | $135.00M | $135.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Deferred Income Tax | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Stock Based Compensation | $- | $- | $- | $- | $11.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Change in Working Capital | $- | $- | $- | $- | $-161.50M | $- | $- | $- | $187.00M | $34.00M | $-86.00M | $-100.00M | $220.00M | $32.00M | $-74.00M | $-165.00M | $- | $- | $-271.00M | $-233.00M |
Accounts Receivables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Inventory | $- | $- | $- | $- | $-161.50M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Accounts Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Working Capital | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Non Cash Items | $-144.00M | $-144.00M | $-223.50M | $-223.50M | $28.00M | $-73.50M | $-349.50M | $-349.50M | $925.00M | $2.00M | $-5.00M | $29.00M | $699.00M | $-14.00M | $-27.00M | $-50.00M | $793.00M | $45.00M | $-39.00M | $17.00M |
Net Cash Provided by Operating Activities | $333.00M | $333.00M | $149.50M | $149.50M | $424.00M | $424.00M | $289.50M | $289.50M | $504.00M | $406.00M | $297.00M | $287.00M | $444.00M | $434.00M | $306.00M | $201.00M | $458.00M | $430.00M | $193.00M | $310.00M |
Investments in Property Plant and Equipment | $-172.50M | $-172.50M | $-149.50M | $-149.50M | $-98.50M | $-98.50M | $-118.00M | $-118.00M | $-214.00M | $-128.00M | $-128.00M | $-156.00M | $-213.00M | $-155.00M | $-121.00M | $-152.00M | $-205.00M | $-152.00M | $-161.00M | $-175.00M |
Acquisitions Net | $- | $- | $- | $- | $- | $- | $- | $- | $-1.53B | $-2.00M | $4.00M | $-3.00M | $-535.00M | $14.00M | $- | $2.00M | $- | $- | $4.00M | $26.00M |
Purchases of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-1.57B | $6.00M | $- | $- |
Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Investing Activities | $948.00M | $948.00M | $-173.50M | $-173.50M | $-292.00M | $-292.00M | $612.50M | $612.50M | $538.00M | $504.00M | $-1.32B | $329.00M | $374.00M | $-47.00M | $143.00M | $-476.00M | $1.48B | $-147.00M | $-225.00M | $-169.00M |
Net Cash Used for Investing Activities | $775.50M | $775.50M | $-323.00M | $-323.00M | $-390.50M | $-390.50M | $494.50M | $494.50M | $-996.00M | $502.00M | $-1.31B | $326.00M | $-161.00M | $-33.00M | $143.00M | $-474.00M | $-100.00M | $-141.00M | $-221.00M | $-143.00M |
Debt Repayment | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock Issued | $- | $- | $- | $- | $- | $- | $- | $- | $15.00M | $15.00M | $17.00M | $16.00M | $16.00M | $28.00M | $81.00M | $55.00M | $6.00M | $33.00M | $41.00M | $17.00M |
Common Stock Repurchased | $- | $- | $-105.00M | $-105.00M | $-22.50M | $-22.50M | $-60.00M | $-60.00M | $- | $-26.00M | $- | $-283.00M | $-421.00M | $-199.00M | $-249.00M | $- | $-23.00M | $-76.00M | $-125.00M | $-12.00M |
Dividends Paid | $-173.00M | $- | $-86.00M | $-86.00M | $-77.00M | $- | $-94.50M | $-94.50M | $- | $-126.00M | $- | $- | $-14.00M | $-119.00M | $- | $- | $- | $- | $- | $- |
Other Financing Activities | $54.50M | $-118.50M | $-132.50M | $-132.50M | $-20.00M | $-97.00M | $-300.50M | $-300.50M | $-320.00M | $-391.00M | $932.00M | $-12.00M | $-377.00M | $-505.00M | $-353.00M | $36.00M | $-65.00M | $-126.00M | $-224.00M | $14.00M |
Net Cash Used Provided by Financing Activities | $-118.50M | $-118.50M | $-218.50M | $-218.50M | $-97.00M | $-97.00M | $-395.00M | $-395.00M | $-320.00M | $-517.00M | $932.00M | $-12.00M | $-391.00M | $-624.00M | $-353.00M | $36.00M | $-65.00M | $-126.00M | $-224.00M | $14.00M |
Effect of Forex Changes on Cash | $-8.50M | $-8.50M | $7.50M | $7.50M | $24.00M | $24.00M | $-4.50M | $-4.50M | $-3.00M | $-5.00M | $-11.00M | $-5.00M | $-18.00M | $12.00M | $-2.00M | $-1.00M | $-9.00M | $21.00M | $-21.00M | $6.00M |
Net Change in Cash | $981.50M | $981.50M | $-384.50M | $-384.50M | $-39.50M | $-39.50M | $384.50M | $384.50M | $-815.00M | $-269.00M | $559.00M | $596.00M | $-126.00M | $-1.36B | $-187.00M | $1.19B | $284.00M | $-822.00M | $-221.00M | $1.14B |
Cash at End of Period | $981.50M | $981.50M | $-384.50M | $-384.50M | $-39.50M | $1.60B | $1.64B | $384.50M | $871.00M | $1.69B | $1.96B | $1.40B | $800.00M | $926.00M | $2.29B | $2.47B | $1.28B | $997.00M | $1.82B | $2.04B |
Cash at Beginning of Period | $- | $- | $- | $- | $- | $1.64B | $1.26B | $- | $1.69B | $1.96B | $1.40B | $800.00M | $926.00M | $2.29B | $2.47B | $1.28B | $997.00M | $1.82B | $2.04B | $899.00M |
Operating Cash Flow | $333.00M | $333.00M | $149.50M | $149.50M | $424.00M | $424.00M | $289.50M | $289.50M | $504.00M | $406.00M | $297.00M | $287.00M | $444.00M | $434.00M | $306.00M | $201.00M | $458.00M | $430.00M | $193.00M | $310.00M |
Capital Expenditure | $-172.50M | $-172.50M | $-149.50M | $-149.50M | $-98.50M | $-98.50M | $-118.00M | $-118.00M | $-214.00M | $-128.00M | $-128.00M | $-156.00M | $-213.00M | $-155.00M | $-121.00M | $-152.00M | $-205.00M | $-152.00M | $-161.00M | $-175.00M |
Free Cash Flow | $160.50M | $160.50M | $- | $- | $325.50M | $325.50M | $171.50M | $171.50M | $290.00M | $278.00M | $169.00M | $131.00M | $231.00M | $279.00M | $185.00M | $49.00M | $253.00M | $278.00M | $32.00M | $135.00M |
Koninklijke DSM N.V Dividends
Explore Koninklijke DSM N.V's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
1.74%
Dividend Payout Ratio
72.63%
Dividend Paid & Capex Coverage Ratio
1.13x
Koninklijke DSM N.V Dividend History
Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
---|---|---|---|---|---|
$0.93 | $0.93 | August 04, 2022 | |||
$1.7 | $1.7 | May 12, 2022 | |||
$0.8 | $0.8 | August 05, 2021 | |||
$1.6 | $1.6 | May 10, 2021 | |||
$0.8 | $0.8 | August 06, 2020 | August 07, 2020 | August 28, 2020 | August 05, 2020 |
$1.63 | $1.63 | May 12, 2020 | May 13, 2020 | June 03, 2020 | May 08, 2020 |
$0.77 | $0.77 | August 05, 2019 | August 06, 2019 | August 26, 2019 | August 01, 2019 |
$1.53 | $1.53 | May 10, 2019 | May 13, 2019 | June 03, 2019 | February 15, 2019 |
$0.77 | $0.77 | August 03, 2018 | August 06, 2018 | August 24, 2018 | August 01, 2018 |
$1.27 | $1.27 | May 11, 2018 | May 14, 2018 | June 01, 2018 | February 15, 2018 |
$1.2 | $1.2 | May 05, 2017 | May 08, 2017 | May 26, 2017 | February 15, 2017 |
$0.55 | $0.55 | August 04, 2016 | August 05, 2016 | August 25, 2016 | August 02, 2016 |
$1.1 | $1.1 | May 03, 2016 | May 04, 2016 | May 24, 2016 | February 17, 2016 |
$0.55 | $0.55 | August 05, 2015 | August 06, 2015 | August 25, 2015 | August 04, 2015 |
$1.1 | $1.1 | May 05, 2015 | May 06, 2015 | May 27, 2015 | February 11, 2015 |
$0.55 | $0.55 | August 06, 2014 | August 08, 2014 | August 27, 2014 | August 05, 2014 |
$1.15 | $1.15 | May 09, 2014 | May 13, 2014 | June 03, 2014 | February 26, 2014 |
$0.5 | $0.5 | August 07, 2013 | August 09, 2013 | August 29, 2013 | August 06, 2013 |
$1.02 | $1.02 | May 07, 2013 | May 09, 2013 | May 29, 2013 | February 20, 2013 |
$0.48 | $0.48 | August 08, 2012 | August 10, 2012 | August 30, 2012 | August 07, 2012 |
Koninklijke DSM N.V News
Read the latest news about Koninklijke DSM N.V, including recent articles, headlines, and updates.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for DSM.AS.